How Merck Is Trying to Keep Disrupters at Bay
Harvard Business Review
JUNE 8, 2015
The lean-startup software ethic of launching minimal viable products in order to fail fast and learn is a challenge in many businesses and especially in healthcare where no one wants a minimum viable pacemaker or “lightly tested” drug. Experimentation is vital.
8 
Let's personalize your content